Myriad Genetics MYGN

€ 14.74 1.57%

Quartalsbericht 2024-Q3
hinzugefügt 08.11.2024

Andere Aktien der Branche "Diagnostik & Forschung"

Name	Preis	% 24h	Marktkapitalisierung	Börse	Land
Genetron Holdings Limited GTH	$ 4.03	0.12 %	$ 80.1 M	Nasdaq Global Market	China
Fluidigm Corporation FLDM	$ 3.75	1.08 %	$ 308 M	Nasdaq Global Select Market	USA
Global Cord Blood Corporation CO	$ 2.99	-	$ 399 M	NYSE	China
Oxford Immunotec Global PLC OXFD	$ 21.99	-	$ 562 M	Nasdaq Global Select Market	Britain
Chembio Diagnostics CEMI	$ 0.46	0.22 %	$ 16.8 M	Nasdaq Capital Market	USA
Bioventus BVS	$ 11.26	-1.3 %	$ 705 M	Nasdaq Global Select Market	USA
ICON Public Limited Company ICLR	$ 205.14	0.72 %	$ 16.8 B	Nasdaq Global Select Market,SPB	Irlanda
IDEXX Laboratories IDXX	$ 411.1	-1.79 %	$ 34.1 B	Nasdaq Global Select Market,SPB	USA
Meridian Bioscience VIVO	$ 33.97	-	$ 1.49 B	Nasdaq Global Select Market	USA
HTG Molecular Diagnostics HTGM	$ 0.48	-20.0 %	$ 1.06 M	Nasdaq Capital Market	USA
Quotient Limited QTNT	$ 0.32	-11.32 %	$ 1.1 M	Nasdaq Global Select Market	Schweiz
Personalis PSNL	$ 2.17	-14.57 %	$ 102 M	Nasdaq Global Select Market	USA
PRA Health Sciences, Inc. PRAH	$ 165.21	-	$ 10.7 B	Nasdaq Global Select Market	USA
Heska Corporation HSKA	$ 119.99	-	$ 1.31 B	Nasdaq Capital Market,SPB	USA
Thermo Fisher Scientific TMO	$ 509.0	-0.73 %	$ 196 B	NYSE,SPB	USA
Agilent Technologies A	$ 129.87	1.0 %	$ 39.5 B	NYSE,SPB	USA
Twist Bioscience Corporation TWST	$ 40.57	-1.31 %	$ 2.35 B	Nasdaq Global Select Market,SPB	USA
DarioHealth Corp. DRIO	$ 0.87	9.25 %	$ 24.7 M	Nasdaq Capital Market	Israel
Motus GI Holdings MOTS	$ 0.17	-34.28 %	$ 263 K	Nasdaq Global Select Market	Israel
Biocept BIOC	$ 0.43	-13.05 %	$ 7.29 M	Nasdaq Capital Market	USA